BVF Inc’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,813,021
| Closed | -$37M | – | 76 |
|
|
2023
Q1 | $37M | Hold |
8,813,021
| – | – | 1.35% | 25 |
|
|
2022
Q4 | $53M | Hold |
8,813,021
| – | – | 2.24% | 12 |
|
|
2022
Q3 | $51.3M | Sell |
8,813,021
-116,669
| -1% | -$727K | 2.12% | 16 |
|
|
2022
Q2 | $53.3M | Hold |
8,929,690
| – | – | 2.57% | 13 |
|
|
2022
Q1 | $41.7M | Hold |
8,929,690
| – | – | 1.67% | 20 |
|
|
2021
Q4 | $22.1M | Hold |
8,929,690
| – | – | 0.8% | 35 |
|
|
2021
Q3 | $26.3M | Hold |
8,929,690
| – | – | 1.03% | 27 |
|
|
2021
Q2 | $22.3M | Buy |
8,929,690
+2,000,000
| +29% | +$4.8M | 0.84% | 30 |
|
|
2021
Q1 | $20.2M | Hold |
6,929,690
| – | – | 0.76% | 33 |
|
|
2020
Q4 | $22.3M | Hold |
6,929,690
| – | – | 0.88% | 31 |
|
|
2020
Q3 | $14.9M | Hold |
6,929,690
| – | – | 0.81% | 37 |
|
|
2020
Q2 | $8.04M | Hold |
6,929,690
| – | – | 0.5% | 44 |
|
|
2020
Q1 | $6.38M | Hold |
6,929,690
| – | – | 0.59% | 33 |
|
|
2019
Q4 | $10.9M | Hold |
6,929,690
| – | – | 0.83% | 27 |
|
|
2019
Q3 | $5.77M | Hold |
6,929,690
| – | – | 0.61% | 41 |
|
|
2019
Q2 | $5.96M | Hold |
6,929,690
| – | – | 0.65% | 39 |
|
|
2019
Q1 | $6.72M | Hold |
6,929,690
| – | – | 0.75% | 37 |
|
|
2018
Q4 | $5.08M | Hold |
6,929,690
| – | – | 0.66% | 38 |
|
|
2018
Q3 | $15M | Hold |
6,929,690
| – | – | 1.32% | 28 |
|
|
2018
Q2 | $34.5M | Hold |
6,929,690
| – | – | 3.37% | 9 |
|
|
2018
Q1 | $27M | Sell |
6,929,690
-1,666,667
| -19% | -$5.86M | 2.74% | 13 |
|
|
2017
Q4 | $23M | Hold |
8,596,357
| – | – | 2.78% | 12 |
|
|
2017
Q3 | $27.4M | Hold |
8,596,357
| – | – | 3.49% | 11 |
|
|
2017
Q2 | $28.5M | Buy |
8,596,357
+4,116,666
| +92% | +$16M | 4.42% | 8 |
|
|
2017
Q1 | $18.8M | Sell |
4,479,691
-3
| -0% | -$14 | 3.2% | 10 |
|
|
2016
Q4 | $18.1M | Hold |
4,479,694
| – | – | 3.63% | 8 |
|
|
2016
Q3 | $16.8M | Hold |
4,479,694
| – | – | 3.16% | 12 |
|
|
2016
Q2 | $15.2M | Hold |
4,479,694
| – | – | 3.24% | 13 |
|
|
2016
Q1 | $23.8M | Buy |
4,479,694
+100,133
| +2% | +$800K | 5.89% | 6 |
|
|
2015
Q4 | $53.9M | Buy |
4,379,561
+3,379,561
| +338% | +$45.1M | 9.18% | 3 |
|
|
2015
Q3 | $14.6M | Buy |
+1,000,000
| New | +$17.3M | 2.95% | 12 |
|
Other funds holding CTIC
BVF Inc's CTIC Position: Q2 2023 in Review
BVF Inc sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 8,813,021 shares — an estimated $37M sold.
BVF Inc first reported a position in CTIC in Q3 2015 and held it in 31 quarters. The position peaked at $53.9M in Q4 2015. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- BVF Inc reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- BVF Inc sold 8,813,021 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $37M.
- BVF Inc first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2015 and held it in 31 quarters.
- BVF Inc's CTI BioPharma Corp. (DE) Common Stock position peaked at $53.9M in Q4 2015.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on BVF Inc's 13F filing for Q2 2023, filed 14 Aug 2023.